Lisa H Butterfield Selected Research

Liver Neoplasms (Liver Cancer)

1/2019	Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
1/2019	Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells.
1/2016	Lessons learned from cancer vaccine trials and target antigen choice.
4/2014	Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.
3/2008	Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.
12/2007	Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
2/2007	Recent advances in immunotherapy for hepatocellular cancer.
7/2006	Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer.
12/2003	T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
2/2002	Immunotherapy of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa H Butterfield Research Topics

Disease

102	Neoplasms (Cancer) 01/2022 - 02/2002
49	Melanoma (Melanoma, Malignant) 01/2022 - 11/2002
13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2002
11	Glioma (Gliomas) 01/2022 - 12/2007
10	Liver Neoplasms (Liver Cancer) 01/2019 - 02/2002
3	Fatigue 01/2020 - 05/2010
3	Squamous Cell Carcinoma of Head and Neck 04/2017 - 06/2012
3	Neoplasm Metastasis (Metastasis) 12/2015 - 11/2014
2	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2020
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2017 - 05/2014
2	Carcinoma (Carcinomatosis) 01/2016 - 05/2010
2	Colitis 01/2015 - 01/2014
2	Diarrhea 01/2015 - 01/2014
2	Pain (Aches) 06/2011 - 05/2010
2	Experimental Melanoma 04/2011 - 06/2005
2	Hepatitis B 02/2007 - 11/2004
1	Adenocarcinoma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Vascular Tissue Neoplasms 11/2021
1	Diffuse Intrinsic Pontine Glioma 12/2020
1	Tertiary Lymphoid Structures 01/2020
1	COVID-19 01/2020
1	Genomic Instability 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Nevus (Nevi) 01/2018
1	Hypersensitivity (Allergy) 01/2018

Drug/Important Bio-Agent (IBA)

45	AntigensIBA 01/2022 - 07/2002
39	VaccinesIBA 01/2022 - 11/2002
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2003
27	Peptides (Polypeptides)IBA 11/2021 - 07/2002
18	CytokinesIBA 01/2020 - 11/2004
16	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2002
15	EpitopesIBA 12/2016 - 03/2003
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019 - 12/2003
12	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2003
10	InterferonsIBA 11/2021 - 12/2007
9	IpilimumabIBA 01/2022 - 09/2012
8	Cancer VaccinesIBA 12/2020 - 10/2007
6	Protein Subunit VaccinesIBA 01/2018 - 02/2009
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 08/2012
6	HLA-A*02:01 antigenIBA 01/2014 - 03/2003
5	Fetal Proteins (Fetoprotein)IBA 01/2022 - 07/2011
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 10/2011
4	Biological ProductsIBA 01/2019 - 06/2012
4	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
3	EnzymesIBA 11/2021 - 12/2007
3	Interleukin-2 (IL2)IBA 01/2020 - 07/2008
3	ChemokinesIBA 01/2019 - 10/2011
3	InterleukinsIBA 01/2019 - 12/2007
3	poly ICLCIBA 01/2016 - 01/2011
3	MART-1 AntigenIBA 01/2016 - 09/2003
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 06/2003
3	AutoantigensIBA 01/2014 - 02/2002
3	Monophenol Monooxygenase (Tyrosinase)IBA 08/2012 - 04/2008
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2016
2	Programmed Cell Death 1 ReceptorIBA 11/2021 - 01/2017
2	pembrolizumabIBA 01/2021 - 11/2017
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	LigandsIBA 12/2020 - 11/2018
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2003
2	Monatide (IMS 3015)IBA 09/2017 - 11/2004
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 12/2004
2	Lysine (L-Lysine)FDA Link 07/2014 - 01/2011
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 01/2011
2	Poly I-CIBA 07/2014 - 01/2011
2	HLA-DR Antigens (HLA-DR)IBA 01/2014 - 01/2014
2	Interleukin-12 (IL 12)IBA 04/2011 - 11/2002
2	Viral AntigensIBA 02/2007 - 11/2004
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	NivolumabIBA 01/2022
1	sotigalimabIBA 01/2022
1	LipidsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	ImmunosorbentsIBA 11/2021
1	Dasatinib (BMS 354825)FDA Link 11/2021
1	dipinacoline glutamateIBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2020
1	AntibodiesIBA 01/2020
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Viral DNAIBA 01/2019
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	ACAM2000IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	afliberceptIBA 11/2018
1	Interferon Type IIBA 01/2018

Therapy/Procedure

61	Immunotherapy 01/2022 - 02/2002
31	Therapeutics 01/2022 - 08/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
5	Biological Therapy 09/2011 - 12/2008
3	Injections 04/2014 - 08/2004
2	Radiotherapy 01/2015 - 12/2007
2	Neoadjuvant Therapy 01/2015 - 06/2012
2	Complementary Therapies (Alternative Medicine) 02/2007 - 11/2004